Login

SB 118-FN - AS AMENDED BY THE HOUSE

 

03/06/2025   0529s

03/20/2025   0941s

8May2025... 1871h

2025 SESSION

25-0349

05/08

 

SENATE BILL 118-FN

 

AN ACT relative to the personal needs allowance of residents of nursing homes; making an appropriation to the department of health and human services for Hampstead hospital and residential treatment facility staff; establishing the Hampstead hospital and residential treatment facility capital investment fund; and permitting qualifying patients and designated caregivers to cultivate cannabis for therapeutic use.

 

SPONSORS: Sen. Birdsell, Dist 19; Sen. Avard, Dist 12; Sen. Prentiss, Dist 5; Sen. Rosenwald, Dist 13; Rep. Weber, Ches. 5; Rep. W. MacDonald, Rock. 16

 

COMMITTEE: Health and Human Services

 

─────────────────────────────────────────────────────────────────

 

AMENDED ANALYSIS

 

This bill:

 

I.  Adjusts the personal needs allowance for nursing home residents to reflect social security increases on an annual basis rather than the current 5-year adjustment.

 

II.  Makes an appropriation to the department of health and human services to fund certain leave accrual and retention payments for temporary classified staff positions at the Hampstead hospital and residential treatment facility.  

 

III.  Establishes the Hampstead hospital and residential treatment facility capital investment fund and provides that all revenue collected by the department of health and human services  from the operations transfer and asset purchase agreements approved by the governor and council on December 18, 2024 be deposited in the fund.

 

IV.  Permits qualifying patients and designated caregivers to cultivate cannabis for therapeutic use.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

03/06/2025   0529s

03/20/2025   0941s

8May2025... 1871h 25-0349

05/08

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Twenty Five

 

AN ACT relative to the personal needs allowance of residents of nursing homes; making an appropriation to the department of health and human services for Hampstead hospital and residential treatment facility staff; establishing the Hampstead hospital and residential treatment facility capital investment fund; and permitting qualifying patients and designated caregivers to cultivate cannabis for therapeutic use.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

1  Personal Needs Allowance of Residents of Nursing Homes.  Amend RSA 167:27-a, II to read as follows:

II.  Every [5 years] year, the commissioner shall make the adjustment for cost of living increases in the personal needs allowance to reflect social security increases.

2  Department of Health and Human Services; Hampstead Hospital and Residential Treatment Facility Staff Transitioning; Certain Leave Accrual and Supplemental Payments; Supplemental Appropriation.  Notwithstanding any other law to the contrary, the sum of $160,000 for the fiscal year ending June 30, 2025, is hereby appropriated to the department of health and human services for the purposes of making certain leave accrual payments to temporary classified positions and any applicable bonus or retention payments prorated to the time worked in state service as part of staff transition at Hampstead hospital and residential treatment facility.  This appropriation shall be nonlapsing and limited to the purposes of this section.  The governor is authorized to draw a warrant for said sum out of any money in the treasury not otherwise appropriated.

3  New Paragraph; Department of Health and Human Services; Hampstead Hospital and Residential Treatment Facility; Establishing Fund.  Amend RSA 126-A:5, by inserting after paragraph XXXVI the following new paragraph:

XXXVII.  There is hereby established the Hampstead hospital and residential treatment facility capital investment fund.  The department shall deposit revenue received through leasing Hampstead hospital and residential treatment facility or any other administrative activities into the fund.  For the biennium ending June 30, 2027, the department shall deposit all revenue into the fund.  In the event that such revenue exceeds $3,000,000, for the biennium ending June 30, 2027, the department shall provide a report to the fiscal committee of the general court identifying the total amount.  The fund shall be nonlapsing and continually appropriated to the commissioner for the purpose of supporting required capital investments and ongoing maintenance and upkeep of the campus at Hampstead hospital and residential treatment facility and may not be transferred or used for any other purpose.

4  Department of Health and Human Services; Carryforward.  For the biennium ending June 30, 2025, all revenue collected by the department of health and human service derived from the operations transfer and asset purchase agreement, lease agreement, and transition services agreement, approved by the governor and executive council on December 18, 2024, shall be deposited into the Hampstead hospital and residential treatment fund.  

5  New Subparagraph; Application of Receipts; Hampstead Hospital and Residential Treatment Facility Capital Investment Fund.  Amend RSA 6:12, I(b) by inserting after subparagraph (399) the following new subparagraph:

(400)  Moneys deposited in the Hampstead hospital and residential treatment facility capital investment fund as established in RSA 126-A:5, XXXVII.

6  Use of Therapeutic Cannabis for Therapeutic Purposes; Definitions.  Amend RSA 126-X:1, IV to read as follows:

IV.  “Cultivation location” means a locked and enclosed site, under the control of an alternative treatment center where cannabis is cultivated, secured with one or more locks or other security devices in accordance with the provisions of this chapter, or under the control of a qualifying patient or designated caregiver where cannabis is cultivated and which meets the requirements of this chapter.  

7  Use of Therapeutic Cannabis; Definitions.  Amend RSA 126-X:1, VI to read as follows:

VI.  "Designated caregiver'' means an individual who:

(a)  Is at least 21 years of age;

(b)(1)  Has agreed to assist with one or more (not to exceed 5) qualifying [patient's] patients in the therapeutic use of cannabis, except if the qualifying patient and designated caregiver each live greater than 50 miles from the nearest alternative treatment center, [in which case] the designated caregiver may assist with the therapeutic use of cannabis for up to 9 qualifying patients; or

(2)  Has agreed to cultivate cannabis for therapeutic use pursuant to this chapter for no more than one qualifying patient;

(c)  Has never been convicted of a felony or any felony drug-related offense; and

(d)  Possesses a valid registry identification card issued pursuant to RSA 126-X:4.

8  New Paragraphs; Use of Cannabis for Therapeutic Purposes; Definitions.  Amend RSA 126-X:1 by inserting after paragraph VI-a the following new paragraphs:

VI-b.  “Immature cannabis plant” means a cannabis plant that has not flowered and which does not have buds that may be observed by visual examination and which is at least 12 inches tall.

VI-c.  “Mature cannabis plant” means a cannabis plant that has flowered and that has buds that may be observed by visual examination.

9  Use of Therapeutic Cannabis; Definitions.  Amend RSA 126-X:1, XIII(c) to read as follows:

(c)  Cultivation by a designated caregiver or qualifying patient, except as provided under RSA 126-X:2, II-a and II-b.

10  New Paragraphs; Use of Therapeutic Cannabis Purposes; Protections.  Amend RSA 126-X:2 by inserting after paragraph II the following new paragraphs:

II-a.  Except as provided in RSA 126-X:3, VII(b), a qualifying patient or designated caregiver who has reported to the department a cultivation location that meets the requirements of this chapter, shall not be subject to arrest by state or local law enforcement, prosecution or penalty under state or municipal law, or denied any right or privilege for the therapeutic use of cannabis in accordance with this chapter, if, at the cultivation location, while transporting cannabis and cannabis plants and seedlings to a new cultivation location that has been reported to the department within the prior 21 days, or while transporting cannabis seedlings from an alternative treatment center to the cultivation location, the qualifying patient or designated caregiver possesses or cultivates an amount of cannabis that does not exceed the following:

(a)  Eight ounces of usable cannabis;

(b)  Any amount of unusable cannabis; and

(c)  Three mature cannabis plants, 3 immature cannabis plants, and 12 seedlings.

II-b.  A cultivation location under the control of a qualifying patient or designated caregiver shall meet the following requirements:

(a)  It shall be at the qualifying patient’s or designated caregiver’s residence.

(b)  It shall be reported to the department, except that either the qualifying patient or their designated caregiver, but not both, shall report a cultivation location to the department.

(c)  It shall be locked and enclosed.

(d)  The cannabis plants shall not be subject to public view, including from another private property, without the use of optical aids.

(e)  It shall have a canopy of no more than 50 square feet, except that if more than one qualifying patient, designated caregiver, or both, share a cultivation location, the total canopy of all cannabis plants shall not exceed 100 square feet.

11  Use of Therapeutic Cannabis; Purposes; Protections.  Amend RSA 126-X:2, III to read as follows:

III.  A designated caregiver may receive compensation for costs, not to exceed $500 per calendar year, not including labor, associated with assisting a qualifying patient who has designated the [designated] caregiver to assist him or her with the therapeutic use of cannabis.  Such compensation shall not constitute the sale of [controlled substances] a controlled drug pursuant to RSA 318-B.

12  Use of Therapeutic Cannabis; Protections.  Amend RSA 126-X:2, XV to read as follows:

XV.  A laboratory, and the employees thereof, which conducts testing of cannabis [required under rules for] delivered to it by alternative treatment centers, [adopted under this chapter, and the employees thereof] qualifying patients, or designated caregivers, shall not be subject to arrest by state or local law enforcement, prosecution or penalty under state or municipal law, or search, for acting pursuant to this chapter and department rules to possess cannabis on the premises of the laboratory for the purposes of testing, and, in the case of a laboratory employee, denied any right or privilege for working for such a laboratory.

13  Use of Therapeutic Cannabis; Prohibitions and Limits.  Amend RSA 126-X:3, I to read as follows:

I.  A qualifying patient may use and a qualifying patient or designated caregiver may cultivate cannabis on privately-owned real property only with written permission of the property owner or, in the case of leased property, with the permission of the tenant in possession of the property, except that a tenant shall not allow a qualifying patient to smoke cannabis on rented property if smoking on the property violates the lease or the lessor's rental policies that apply to all tenants at the property.  A tenant or guest of a tenant shall not cultivate cannabis on rented property if the lessor has prohibited therapeutic cannabis cultivation. However, a tenant may permit a qualifying patient to use cannabis on leased property by ingestion or inhalation through vaporization even if smoking is prohibited by the lease or rental policies.  For purposes of this chapter, vaporization shall mean the inhalation of cannabis without the combustion of the cannabis.

14  New Subparagraph; Use of Therapeutic Cannabis; Registry Identification Cards.  Amend RSA 126-X:4, I by inserting after subparagraph (h) the following new subparagraph:

(i)  The qualifying patient's cultivation location, if any.

15  New Subparagraph; Use of Therapeutic Cannabis; Registry Identification Cards.  Amend RSA 126-X:4, II by inserting after subparagraph (h) the following new subparagraph:

(i)  The designated caregiver's cultivation location, where he or she may cultivate cannabis on behalf of a single qualifying patient who has not reported a cultivation location.

16  Use of Therapeutic Cannabis; Registry Identification Cards.  Amend RSA 126-X:4, IX(a) to read as follows:

IX.(a)  A qualifying patient shall notify the department before changing his or her designated caregiver or cultivation location.  A designated caregiver shall notify the department before changing his or her cultivation location.

17  Use of Therapeutic Cannabis; Registry Identification Cards.  Amend RSA 126-X:4, XI to read as follows:

XI.(a)  The department shall create and maintain a confidential registry of each individual who has applied for and received a registry identification card as a qualifying patient or a designated caregiver in accordance with the provisions of this chapter.  Each entry in the registry shall contain the qualifying patient's or designated caregiver's name, mailing address, date of birth, date of registry identification card issuance, effective date of the registry identification card, date of registry identification card expiration, [and] random 10-digit identification number, and cultivation location, if any.  The confidential registry and the information contained in it shall be exempt from disclosure under RSA 91-A.

(b)(1)  Except as specifically provided in this chapter, no person shall have access to any information about qualifying patients or designated caregivers in the department's confidential registry, or any information otherwise maintained by the department about providers and alternative treatment centers, except for authorized employees of the department in the course of their official duties and local and state law enforcement personnel who have detained or arrested an individual who claims to be engaged in the therapeutic use of cannabis.

(2)  If a local or state law enforcement officer submits a sworn affidavit to the department affirming that he or she has probable cause to believe cannabis is possessed or cultivated at a specific address, an authorized employee for the department may disclose whether the location is associated with a qualifying patient, designated caregiver, or cultivation location [of an alternative treatment center].

(3)  If a local or state law enforcement officer submits a sworn affidavit to the department affirming that he or she has probable cause to believe a specific individual possesses or cultivates cannabis, an authorized employee for the department may disclose whether the person is a qualifying patient or a designated caregiver, provided that the law enforcement officer provides the person's name and address or name and date of birth.

(4)  Requests by law enforcement officials under this section to the department pursuant to a sworn affidavit, search warrant, or court order, regardless of whether or not the name or address was found in the registry, shall be confidential under this chapter and exempt from disclosure under RSA 91-A.  Aggregate data relative to such requests may be made public if it does not contain any identifying information regarding the specific law enforcement request.

(5)  Counsel for the department may notify law enforcement officials about falsified or fraudulent information submitted to the department where counsel has reason to believe the information is false or falsified.

18  New Paragraph; Use of Therapeutic Cannabis; Registry Identification Cards.  Amend RSA 126-X:4 by inserting after paragraph XII the following new paragraph:

XIII.(a)  No later than December 1, 2025, the department shall allow existing and new qualifying patients and designated caregivers to report a cultivation location provided that:

(1)  A qualifying patient may report a cultivation location only if he or she does not have a designated caregiver who has reported a cultivation location.

(2)  A designated caregiver may report a cultivation location only if he or she does not have a qualifying patient who has reported a cultivation location.

(b)  No individual shall report a cultivation location if such individual's permission to cultivate has been revoked pursuant to RSA 126-X:3, VIII(b).

19  Use of Therapeutic Cannabis; Affirmative Defense.  Amend RSA 126-X:5, I to read as follows:

I.  It shall be an affirmative defense for any person charged with manufacturing, possessing, having under his or her control, selling, purchasing, prescribing, administering, transporting, or possessing with intent to sell, dispense, or compound cannabis, cannabis analog, or any preparation containing cannabis, if:

(a)  The actor is a qualifying patient who has been issued a valid registry identification card, was in possession of cannabis in a quantity and location permitted pursuant to this chapter, and was engaged in the therapeutic use of cannabis;

(b)  The actor is a designated caregiver who has been issued a valid registry identification card, was in possession of cannabis in a quantity and location permitted pursuant to this chapter, and was engaged in the therapeutic use of cannabis on behalf of a qualifying patient; or

(c)  The actor is an employee of a laboratory conducting testing required for alternative treatment centers pursuant to rules adopted under this chapter or that tests cannabis provided to it by qualifying patients and designated caregivers.

20  New Subparagraph; Use of Therapeutic Cannabis; Alternative Treatment Centers.  Amend RSA 126-X:8, XIII by inserting after subparagraph (c) the following new subparagraph:

(d)  A qualifying patent or designated caregiver shall not obtain from an alternative treatment center more than 12 seedlings during a 3-month period.

21  Use of Cannabis for Therapeutic Purposes; Prohibitions and Limits.  Amend RSA 126-X:3, VII to read as follows:

VII.(a) The department may revoke the registry identification card of a qualifying patient or designated caregiver for violation of rules adopted by the department or for violation of any other provision of this chapter, including for obtaining more than 2 ounces of cannabis in any 10-day period in violation of RSA 126-X:8, XIII(b), and the qualifying patient or designated caregiver shall be subject to any other penalties established in law for the violation.

(b)  The department may revoke a qualifying patient's or designated caregiver’s permission to cultivate cannabis for a violation of the rules adopted by the department or for a violation of any provision of this chapter.

22  Use of Cannabis for Therapeutic Purposes; Alternative Treatment Centers.  Amend RSA 126-X:8, XV(a) to read as follows:

XV.(a)(1)  An alternative treatment center shall not possess or cultivate cannabis in excess of the following quantities:

[(1)] (A)  Eighty mature cannabis plants, 160 [seedlings] immature cannabis plants, and 80 ounces of usable cannabis[, or 6 ounces of usable cannabis per qualifying patient]; and

[(2)] (B)  Three mature cannabis plants, 12 [seedlings] immature cannabis plants, and 6 ounces of usable cannabis for each qualifying patient registered [as a qualifying patient] under this chapter.

(2)  An alternative treatment center shall not be limited in the number of seedlings it can possess or cultivate.

23  Use of Cannabis for Therapeutic Purposes; Departmental Rules.  Amend RSA 126-X:6, III(a)(15) to read as follows:

(15)  Procedures for determining and enforcing the daily maximum amount of therapeutic cannabis which an alternative treatment center may cultivate or possess pursuant to RSA 126-X:8, XV(a)(1).

24  Effective Date.

I.  Section 1 of this act shall take effect January 1, 2026.

II.  Sections 3, 4, and 5 shall take effect June 30, 2025.

III.  The remainder of this act shall take effect July 1, 2025.

 

LBA

25-0349

3/11/25

 

SB 118-FN- FISCAL NOTE

AS AMENDED BY THE SENATE (AMENDMENT #2025-0529s)

 

AN ACT relative to the personal needs allowance of residents of nursing homes; making an appropriation to the department of health and human services for Hampstead hospital and residential treatment facility staff; and establishing the Hampstead hospital and residential treatment facility capital investment fund.

 

FISCAL IMPACT:   This bill does not authorize new positions.

 

 

Estimated State Impact

 

FY 2025

FY 2026

FY 2027

FY 2028

Revenue

$0

$0

$0

$0

Revenue Fund(s)

None

Expenditures*

$0

$185,000 to $210,000 general funds; $25,000 to $50,000 federal funds

$50,000 to $250,000 general funds; $50,000 to $250,000 federal funds

$50,000 to $250,000 general funds; $50,000 to $250,000 federal funds

Funding Source(s)

General Fund, Federal Funds

Appropriations*

$0

$160,000

$0

$0

Funding Source(s)

General Fund

*Expenditure = Cost of bill                *Appropriation = Authorized funding to cover cost of bill

 

METHODOLOGY:

This bill requires the Department of Health and Human Services to adjust the personal needs allowance for nursing home residents every year, rather than every five years as under current statute.  The Department notes that nursing facility residents that receive Medicaid are expected to contribute part of their income to the cost of their care; the personal needs allowance is a small allowance that those residents are allowed to retain.  An annual update to the personal needs allowance will therefore result in an indeterminable increase in state expenditures, since the Medicaid program will pay more for nursing facility services as the allowance increases due to inflation.  There will be no fiscal impact in years ending in 0 or 5, as this is when the Department would adjust the allowance under current law.  Since the Department is unable to predict inflation with a high degree of certainty, it assumes a cost increase of between $50,000 and $100,000 in FY26 and between $100,000 and $500,000 in subsequent years.  This cost would be paid for with 50 percent state general funds and 50 percent matching federal funds.

 

In addition, the bill appropriates $160,000 in FY26 for the purposes of making leave accrual or other payments related to staff transitions out of the state classification system at Hampstead Hospital.  Finally, the bill establishes a Hampstead Hospital and residential treatment facility capital investment fund, which is authorized to accept up to $3 million of revenue received through the lease of Hampstead Hospital.  The fund may also accept federal or other funds approved by the Fiscal Committee, as well as funds appropriated as part of the state operating budget.

 

AGENCIES CONTACTED:

Department of Health and Human Services